Mirae Asset Global Investments Co., Ltd. Novo Nordisk A S Transaction History

Mirae Asset Global Investments Co., Ltd.

$20 Billion
Q2 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Novo Nordisk A S stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 276,599 shares of NVO stock, worth $32.2 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

276,599

Previous 244,301 13.22%

Holding current value

$32.2 Million

Previous $31.4 Million 25.86%

% of portfolio

0.2%

Previous 0.06%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$122.71 - $146.91 $3.96 Million - $4.74 Million	32,298 Added 13.22%	276,599 $39.5 Million
Q1 2024 May 01, 2024	BUY	$102.11 - $135.92 $5.72 Million - $7.62 Million	56,060 Added 29.78%	244,301 $31.4 Million
Q4 2023 Jan 24, 2024	SELL	$87.78 - $105.45 $207,511 - $249,283	-2,364 Reduced 1.24%	188,241 $19.5 Million
Q3 2023 Oct 26, 2023	BUY	$90.94 - $199.54 $9.42 Million - $20.7 Million	103,545 Added 118.94%	190,605 $17.3 Million
Q2 2023 Aug 10, 2023	BUY	$155.98 - $172.65 $3.51 Million - $3.88 Million	22,495 Added 34.84%	87,060 $14.1 Million
Q1 2023 May 04, 2023	SELL	$132.34 - $159.14 $16.3 Million - $19.5 Million	-122,832 Reduced 65.55%	64,565 $10.3 Million
Q4 2022 Feb 09, 2023	BUY	$102.55 - $135.33 $9.87 Million - $13 Million	96,291 Added 105.69%	187,397 $25.4 Million
Q3 2022 Nov 10, 2022	SELL	$95.28 - $116.93 $2.2 Million - $2.7 Million	-23,077 Reduced 20.21%	91,106 $9.1 Million
Q2 2022 Jul 26, 2022	BUY	$103.24 - $121.81 $5.22 Million - $6.16 Million	50,584 Added 79.54%	114,183 $10.1 Million
Q1 2022 May 10, 2022	SELL	$93.1 - $112.54 $77,366 - $93,520	-831 Reduced 1.29%	63,599 $7.06 Million
Q4 2021 Feb 08, 2022	SELL	$95.88 - $117.08 $241,138 - $294,456	-2,515 Reduced 3.76%	64,430 $7.22 Million
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $235,278 - $297,149	2,787 Added 4.34%	66,945 $6.43 Million
Q2 2021 Aug 11, 2021	SELL	$67.66 - $84.76 $76,726 - $96,117	-1,134 Reduced 1.74%	64,158 $5.37 Million
Q1 2021 May 13, 2021	SELL	$67.06 - $75.82 $35.4 Million - $40 Million	-527,851 Reduced 88.99%	65,292 $4.4 Million
Q4 2020 Feb 10, 2021	BUY	$63.89 - $73.8 $16.8 Million - $19.5 Million	263,648 Added 80.02%	593,143 $41.4 Million
Q3 2020 Nov 12, 2020	BUY	$63.69 - $70.22 $1.42 Million - $1.56 Million	22,246 Added 7.24%	329,495 $22.8 Million
Q2 2020 Aug 11, 2020	BUY	$58.54 - $67.94 $11.5 Million - $13.3 Million	195,949 Added 176.05%	307,249 $20.1 Million
Q1 2020 May 12, 2020	SELL	$49.46 - $64.78 $977,824 - $1.28 Million	-19,770 Reduced 15.08%	111,300 $6.7 Million
Q4 2019 Feb 12, 2020	BUY	$49.86 - $58.26 $3.23 Million - $3.77 Million	64,793 Added 97.76%	131,070 $7.59 Million
Q1 2019 May 13, 2019	BUY	$46.36 - $52.63 $494,012 - $560,825	10,656 Added 19.16%	66,277 $3.47 Million
Q4 2018 Feb 11, 2019	SELL	$41.54 - $47.25 $1.65 Million - $1.87 Million	-39,616 Reduced 41.6%	55,621 $2.56 Million
Q3 2018 Nov 13, 2018	BUY	$46.76 - $51.24 $1.19 Million - $1.31 Million	25,488 Added 36.54%	95,237 $4.49 Million
Q2 2018 Aug 14, 2018	SELL	$44.29 - $50.42 $1.91 Million - $2.17 Million	-43,078 Reduced 38.18%	69,749 $3.22 Million
Q1 2018 May 10, 2018	BUY	$48.49 - $58.14 $371,821 - $445,817	7,668 Added 7.29%	112,827 $5.56 Million
Q4 2017 Feb 12, 2018	BUY	$47.53 - $53.73 $1.56 Million - $1.77 Million	32,910 Added 45.55%	105,159 $5.64 Million
Q3 2017 Nov 08, 2017	BUY	$41.15 - $49.22 $248,628 - $297,387	6,042 Added 9.13%	72,249 $3.48 Million
Q2 2017 Aug 14, 2017	BUY	N/A	66,207	66,207 $2.83 Million

Others Institutions Holding NVO

# of Institutions

1,991

Shares Held

318M

Call Options Held

5.23M

Put Options Held

4.97M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $263B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Novo Nordisk A S Transaction History